GL1X · GenesisL1 explorer

MolNFT v1 · #188750 · protein

Structure of the SARS-cov-2 ntd in complex with C1520, local refinement

7UAQ · Spike glycoprotein: “Structure of the SARS-cov-2 ntd in complex with C1520, local refinement”. Electron microscopy, 1 ligand (NAG), 7 pockets (best druggability 0.69). MolNFT v1 #188750 on GenesisL1: 3D structure, binding sites and…

PDB
7UAQ
Type
protein
Length
533 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein; C1520 Fab heavy chain; C1520 Fab light chain
UniProt
P0DTC2
Ligands
NAG
Pockets
7 · best druggability 0.69

Structure

electron microscopy · 3 distinct chains · 3% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike glycoproteinprotein2953% helix, 37% strandP0DTC2
HC1520 Fab heavy chainprotein1262% helix, 37% strand—
LC1520 Fab light chainprotein1125% helix, 34% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A, H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.690.9525empty
22350.610.8133empty
3750.520.8525empty
41220.520.8123empty
51800.460.7529empty

Interfaces

3 interfaces between chains.

  • A–H · 949 Ų buried · 12 hydrogen bonds · protein-protein
  • H–L · 926 Ų buried · 11 hydrogen bonds · protein-protein
  • A–L · 236 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 glycan, 5 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7UAQ · Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.